Mission
MEMORIAL SLOAN-KETTERING CANCER CENTER IS DEDICATED TO THIS MISSION: LEADERSHIP IN THE PREVENTION, TREATMENT, AND CURE OF CANCER THROUGH EXCELLENCE, VISION, AND COST-EFFECTIVENESS IN PATIENT CARE, OUTREACH PROGRAMS, RESEARCH, AND EDUCATION.
Public Charity
MEMORIAL SLOAN-KETTERING CANCER CENTER
MEMORIAL SLOAN-KETTERING CANCER CENTER, of NEW YORK, NY, is a Public Charity tracked in Imperigo's IRS 990 database. The 2024 filing shows $1.8B in revenue, $1.6B in expenses, $9.2B in total assets. 1,269 publicly reported grants to this organization, totaling roughly $676.6M, appear in IRS filings.
EIN: 131924236
NEW YORK, NY
Latest filing: 2024
Total Revenue$1.8B
Total Expenses$1.6B
Total Assets$9.2B
Grant Records1,269
Funding Total$676.6M
Filing Years2019–2024
Sample Grants Received
SUPPORT EWING SARCOMA CANCER RESEARCH
$160,000
This project to identify factors that influence the Loss of Heterozygosity (LOH) was initially funded in 2019. Based on the significant progress made in the project, the project was granted additional funding to continue to phase 2 in 2021 and phase 3 in 2024-2025. During phase 3, they will study allele loss under BRCA wildtype and heterozygous conditions. These studies will provide a comparative mechanistic understanding of LOH at BRCA under normal and carrier conditions. This mechanistic understanding will facilitate development of strategies to prevent LOH and thereby prevent cancer development in high-risk individuals.
$150,000
GENERAL PURPOSES
$83,100
RESEARCH BREAST CANC
$25,000
MEDICAL RESERCH
$25,000
Showing up to 5 of 1,269 total records — full history available with membership.
Officers & Directors
Board Member
Alan Schnitzer
Board Member
Alexander T Robertson
FORMER SVP FACILITIES MGMT & REAL ESTATE DEVELOPMENT
Amador Centeno
EVP, CHIEF STRATEGY OFFICER
Anaeze Offodile Md
Board Member
Anthony B Evnin
Board Member
Benjamin W Heineman Jr
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $1.8B | $1.6B | $9.2B |
| 2023 | $1.7B | $1.5B | $8.5B |
| 2022 | $1.8B | $1.5B | $7.9B |
| 2020 | $1.1B | $1.1B | $6.8B |
| 2019 | $999.2M | $992.6M | $5.7B |
Between 2019 and 2024, reported annual revenue grew from $999.2M to $1.8B (+82%), with total assets most recently reported at $9.2B.
Interactive year-over-year charts and full filing details available with membership.